These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1188907)

  • 1. [Editorial: Lisidonil (hydramitrazine) in treatment of unchecked neurogenic urinary bladder].
    Jensen D
    Tidsskr Nor Laegeforen; 1975 Nov; 95(33):1930-2. PubMed ID: 1188907
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of hydramitrazine (Lisidonil) in the treatment of neurogenic bladder dysfunction.
    Pedersen E; Grynderup V
    Br Med J; 1966 Jul; 2(5508):271-3. PubMed ID: 4380285
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical application of eperisone hydrochloride to neurogenic bladder].
    Murayama K; Katsumi T; Tajika E; Nakamura T
    Hinyokika Kiyo; 1984 Mar; 30(3):403-8. PubMed ID: 6464913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYSTOMETRIC STUDIES OF THE EFFECT OF LISIDONIL UPON THE BLADDER.
    KOLLBERG S; PETERSEN I
    Urol Int; 1963; 16():46-64. PubMed ID: 14061238
    [No Abstract]   [Full Text] [Related]  

  • 5. The neurogenic bladder.
    Pedersen E
    Scand J Rehabil Med; 1971; 3(1):67-76. PubMed ID: 4405584
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical studies on the urethral function of the neurogenic bladder in multiple sclerosis.
    Pedersen E
    Acta Neurol Belg; 1972; 72(4):254-64. PubMed ID: 4675968
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intrathecal therapy for bladder hyperreflexia].
    Denys P; Even-Schneider A; Rémy-Néris O; Ben Smaïl D; Chartier-Kastler E; Bussel B
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):395-8. PubMed ID: 12746716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination of drugs and clean intermittent catheterization in the treatment of neurogenic bladder. Effect on continence].
    Jiménez J; Arruebarrena D; Rodríguez J; Urbieta MA; Arriola M; Aresès R
    An Esp Pediatr; 1987 Nov; 27(5):343-6. PubMed ID: 3439656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial comment on: Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
    Novara G
    Eur Urol; 2008 Mar; 53(3):618-9. PubMed ID: 17804151
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment on: botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence.
    Kocjancic E
    Eur Urol; 2007 Sep; 52(3):858-9. PubMed ID: 17467880
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
    Haferkamp A
    Eur Urol; 2008 Jun; 53(6):1253. PubMed ID: 18343561
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of urinary incontinence in neurogenic bladder].
    da Silva Peres OR
    Rev Bras Med; 1969 Apr; 26(4):251-2. PubMed ID: 5800218
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies.
    Denys P; Corcos J; Everaert K; Chartier-Kastler E; Fowler C; Kalsi V; Nitti V; Schulte-Baukloh H; Schurch B
    Curr Med Res Opin; 2006 May; 22(5):851-60. PubMed ID: 16709307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of systemic lupus erythematosus (SLE) with a neurogenic bladder, successful treatment with intravenous cyclophosphamide pulse therapy].
    Nakagawa M; Nishinarita M
    Ryumachi; 1999 Oct; 39(5):763-7. PubMed ID: 10614171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial comment on: Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Fowler CJ
    Eur Urol; 2009 Mar; 55(3):712. PubMed ID: 18814958
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment on: Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Schurch B
    Eur Urol; 2009 Mar; 55(3):711-2. PubMed ID: 18814956
    [No Abstract]   [Full Text] [Related]  

  • 17. [Validation of the treatment of the neurogenic bladder in children with myelodysplasia using pikamilon].
    Vishnevskiĭ EL; Guseva NB
    Urol Nefrol (Mosk); 1998; (2):27-30. PubMed ID: 9577700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of neurogenic bladder secondary to myelomeningocele based on the urodynamic status with intermittent catheterization associated with drugs. Preliminary results].
    Castro-Gago M; Marqués-Queimadelos A; Cimadevila A; Novo I; Peña J
    An Esp Pediatr; 1987 Feb; 26(2):103-6. PubMed ID: 3565950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurogenic disturbances of the bladder treated with flavoxate (Urispadol)].
    Pedersen E; Bjarnason EV; Hansen PH
    Ugeskr Laeger; 1973 Oct; 135(43):2313-7. PubMed ID: 4590632
    [No Abstract]   [Full Text] [Related]  

  • 20. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
    Reitz A; Stöhrer M; Kramer G; Del Popolo G; Chartier-Kastler E; Pannek J; Burgdörfer H; Göcking K; Madersbacher H; Schumacher S; Richter R; von Tobel J; Schurch B
    Eur Urol; 2004 Apr; 45(4):510-5. PubMed ID: 15041117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.